Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Medidata Solutions, Inc. (“Medidata”) (NASDAQ GS: MDSO) common stock in connection with the proposed acquisition of Medidata by affiliates of Dassault Systèmes SE (“Dassault”), announced on June 12, 2019 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Medidata and its Board of Directors (the “Board”), is captioned Kent v. Medidata Solutions, Inc., Case No. 1:19-cv-01361 (D. Del.).

On June 11, 2019, Medidata entered into an agreement and plan of merger (the “Merger Agreement”) with Dassault. Pursuant to the terms of the Merger Agreement, shareholders of Medidata will receive $92.25 per share in cash (the “Proposed Transaction”).

Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a proxy statement (the “Proxy Statement”) filed with the United States Securities and Exchange Commission. The Complaint alleges that the Proxy Statement omits material information with respect to, among other things, Medidata’s financial projections and the analyses performed by Medidata’s financial advisor. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of Medidata common stock.

If you wish to serve as lead plaintiff, you must move the Court no later than September 23, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.